{"id":"NCT02828020","sponsor":"Allergan","briefTitle":"Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine","officialTitle":"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Single Attack Study to Evaluate the Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-07-22","primaryCompletion":"2017-12-13","completion":"2017-12-14","firstPosted":"2016-07-11","resultsPosted":"2019-01-03","lastUpdate":"2019-01-03"},"enrollment":1672,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Migraine, With or Without Aura"],"interventions":[{"type":"DRUG","name":"Ubrogepant","otherNames":[]},{"type":"DRUG","name":"Placebo-matching Ubrogepant","otherNames":[]}],"arms":[{"label":"Ubrogepant 50 mg","type":"EXPERIMENTAL"},{"label":"Ubrogepant 100 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (50 and 100 mg) compared to placebo for the acute treatment of a single migraine attack.","primaryOutcome":{"measure":"Percentage of Participants With Pain Freedom at 2 Hours After Initial Dose","timeFrame":"Baseline (Predose) to 2 hours after initial dose","effectByArm":[{"arm":"Placebo","deltaMin":11.8,"sd":null},{"arm":"Ubrogepant 50 mg","deltaMin":19.2,"sd":null},{"arm":"Ubrogepant 100 mg","deltaMin":21.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0023"},{"comp":"OG000 vs OG002","p":"0.0003"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":9},"locations":{"siteCount":90,"countries":["United States"]},"refs":{"pmids":["39982105","36125279","35468729","34874514","33874756","33608814","33241721","31800988"],"seeAlso":["http://www.allerganclinicaltrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":485},"commonTop":[]}}